 Connection
David Lynch to Trinucleotide Repeats
This is a "connection" page, showing publications David Lynch has written about Trinucleotide Repeats.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.951 |
|
|
|
-
Lynch DR, Kichula E. Challenges ahead for trials in Friedreich's ataxia. Lancet Neurol. 2016 12; 15(13):1300-1301.
Score: 0.586
-
Rodden LN, Rummey C, Kessler S, Wilson RB, Lynch DR. A Novel Metric for Predicting Severity of Disease Features in Friedreich's Ataxia. Mov Disord. 2023 06; 38(6):970-977.
Score: 0.227
-
Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
Score: 0.092
-
Mahishi LH, Hart RP, Lynch DR, Ratan RR. miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci. 2012 Jul 04; 32(27):9369-73.
Score: 0.027
-
Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H. Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments. Mol Genet Metab. 2007 Sep-Oct; 92(1-2):23-35.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|